16:31 EDT Vir Biotechnology trading resumes
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIR:
- Vir gets FDA clearance, fast track designation for tobevibart and elebsiran
- Biotech Alert: Searches spiking for these stocks today
- Vir Biotechnology price target raised to $15 from $12 at Morgan Stanley
- Vir Biotechnology price target raised to $13 from $12 at JPMorgan
- Vir Biotechnology combo shows ‘unprecedented’ response, says H.C. Wainwright